Lv7
3855 积分 2021-11-11 加入
天下本无事，庸人自扰之~
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
3天前
已完结
The dual role of PCDH9 in tumors, neurological and developmental diseases
13天前
已完结
Liquid biopsies across the cancer care continuum
19天前
已完结
BRAF fusions define therapeutic vulnerability and tyrosine kinase inhibitor resistance in non-small cell lung cancer
19天前
已完结
Current and future perspectives of liquid biopsies in genomics-driven oncology
19天前
已完结
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial
30天前
已完结
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer
1个月前
已关闭
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer
1个月前
已完结
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
1个月前
已完结
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
1个月前
已完结
皖公网安备34019202002308
